Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis Inc. reports a successful fiscal Q1 2025 with a 12% year-over-year increase in net revenue, totaling $83.4 million, and a notable rise in global medical cannabis sales. The company achieved $6.5 million in positive free cash flow and an 87% growth in adjusted EBITDA, all while maintaining a debt-free cannabis operation and a strong cash position of approximately $182 million.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
